ASP7317

AssetCell therapy

Replaces degenerate retinal pigment epithelium cells with embryonic stem cell-derived RPE cells.

Stage
Phase 1
Modality
Cell therapy
Target
Stem cell maintenance
Indications
1
Trials
0
Developers
1

Indications

1
  • Targets and what it contains1
  • Owner and partners1
  • Evidence for its targets1
  • Competitors1
  • Aging relevance1

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Updated 7 Oct 2026 · 1 source

Assets